tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

CALC Stock Latest News

Calcimedica’s Auxora Study: A Potential Game-Changer for AKI Treatment
Company AnnouncementsCalcimedica’s Auxora Study: A Potential Game-Changer for AKI Treatment
9d ago
CALC
CalciMedica and Telperian collaborate to integrate AI to Auxora clinical trials
PremiumThe Fly
CalciMedica and Telperian collaborate to integrate AI to Auxora clinical trials
23d ago
CALC
CalciMedica’s Promising Clinical Advancements and Financial Stability Support Buy Rating
PremiumRatings
CalciMedica’s Promising Clinical Advancements and Financial Stability Support Buy Rating
3M ago
CALC
CalciMedica reports Q2 EPS (40c) vs. (36c) last year
PremiumThe Fly
CalciMedica reports Q2 EPS (40c) vs. (36c) last year
3M ago
CALC
CalciMedica Stockholders Approve Equity Plan Amendment
PremiumCompany Announcements
CalciMedica Stockholders Approve Equity Plan Amendment
4M ago
8K
CALC
CalciMedica announces publication on Kourage trial in AJN
PremiumThe FlyCalciMedica announces publication on Kourage trial in AJN
4M ago
CALC
CalciMedica’s Strong Financial Position and Promising Clinical Pipeline Justify Buy Rating
Premium
Ratings
CalciMedica’s Strong Financial Position and Promising Clinical Pipeline Justify Buy Rating
7M ago
CALC
CalciMedica says cash sufficient to fund operating plan into mid-2026
Premium
The Fly
CalciMedica says cash sufficient to fund operating plan into mid-2026
7M ago
CALC
CALC Earnings this Week: How Will it Perform?
PremiumPre-Earnings
CALC Earnings this Week: How Will it Perform?
8M ago
CALC
Promising Phase 2 Results and Market Potential Drive Buy Rating for CalciMedica’s Auxora
PremiumRatings
Promising Phase 2 Results and Market Potential Drive Buy Rating for CalciMedica’s Auxora
8M ago
CALC
CalciMedica Highlights Auxora’s Potential in COVID-19 Treatment
PremiumCompany Announcements
CalciMedica Highlights Auxora’s Potential in COVID-19 Treatment
8M ago
8K
CALC
CalciMedica’s Auxora shows mortality reduction in COVID-19 pneumonia trial
PremiumThe Fly
CalciMedica’s Auxora shows mortality reduction in COVID-19 pneumonia trial
8M ago
CALC
CalciMedica Announces Board Changes and New Appointment
PremiumCompany AnnouncementsCalciMedica Announces Board Changes and New Appointment
10M ago
8K
CALC
CalciMedica initiated with a Buy at Lucid Capital
Premium
The Fly
CalciMedica initiated with a Buy at Lucid Capital
11M ago
CALC
CalciMedica reports Q3 EPS (50c), consensus (50c)
Premium
The Fly
CalciMedica reports Q3 EPS (50c), consensus (50c)
12M ago
CALC
CalciMedica Appoints Stephen Bardin as New CFO
PremiumCompany Announcements
CalciMedica Appoints Stephen Bardin as New CFO
12M ago
8K
CALC
CalciMedica name Stephen Bardin as CFO
PremiumThe Fly
CalciMedica name Stephen Bardin as CFO
12M ago
CALC
CalciMedica price target lowered to $16 from $20 at H.C. Wainwright
PremiumThe Fly
CalciMedica price target lowered to $16 from $20 at H.C. Wainwright
1y ago
CALC
CalciMedica announces common stock offering, no amount given
PremiumThe Fly
CalciMedica announces common stock offering, no amount given
1y ago
CALC
CalciMedica’s Promising Phase 2b Trial Results for Auxora
PremiumCompany AnnouncementsCalciMedica’s Promising Phase 2b Trial Results for Auxora
1y ago
8K
CALC
CalciMedica Shareholders Back Expansion and Elect Directors
Premium
Company Announcements
CalciMedica Shareholders Back Expansion and Elect Directors
1y ago
8K
CALC
CalciMedica director buys $201K in common stock
Premium
The Fly
CalciMedica director buys $201K in common stock
1y ago
CALC

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >